248 related articles for article (PubMed ID: 17601930)
1. De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features.
Søvik O; Schubbert S; Houge G; Steine SJ; Norgård G; Engelsen B; Njølstad PR; Shannon K; Molven A
J Med Genet; 2007 Jul; 44(7):e84. PubMed ID: 17601930
[TBL] [Abstract][Full Text] [Related]
2. De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features.
Søvik O; Schubbert S; Houge G; Steine SJ; Norgård G; Engelsen B; Njølstad PR; Shannon K; Molven A
BMJ Case Rep; 2009; 2009():. PubMed ID: 21686750
[TBL] [Abstract][Full Text] [Related]
3. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
Nava C; Hanna N; Michot C; Pereira S; Pouvreau N; Niihori T; Aoki Y; Matsubara Y; Arveiler B; Lacombe D; Pasmant E; Parfait B; Baumann C; Héron D; Sigaudy S; Toutain A; Rio M; Goldenberg A; Leheup B; Verloes A; Cavé H
J Med Genet; 2007 Dec; 44(12):763-71. PubMed ID: 17704260
[TBL] [Abstract][Full Text] [Related]
4. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
Tidyman WE; Rauen KA
Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751
[TBL] [Abstract][Full Text] [Related]
5. Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome.
Schulz AL; Albrecht B; Arici C; van der Burgt I; Buske A; Gillessen-Kaesbach G; Heller R; Horn D; Hübner CA; Korenke GC; König R; Kress W; Krüger G; Meinecke P; Mücke J; Plecko B; Rossier E; Schinzel A; Schulze A; Seemanova E; Seidel H; Spranger S; Tuysuz B; Uhrig S; Wieczorek D; Kutsche K; Zenker M
Clin Genet; 2008 Jan; 73(1):62-70. PubMed ID: 18042262
[TBL] [Abstract][Full Text] [Related]
6. Costello syndrome and related disorders.
Quezada E; Gripp KW
Curr Opin Pediatr; 2007 Dec; 19(6):636-44. PubMed ID: 18025929
[TBL] [Abstract][Full Text] [Related]
7. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.
Niihori T; Aoki Y; Narumi Y; Neri G; Cavé H; Verloes A; Okamoto N; Hennekam RC; Gillessen-Kaesbach G; Wieczorek D; Kavamura MI; Kurosawa K; Ohashi H; Wilson L; Heron D; Bonneau D; Corona G; Kaname T; Naritomi K; Baumann C; Matsumoto N; Kato K; Kure S; Matsubara Y
Nat Genet; 2006 Mar; 38(3):294-6. PubMed ID: 16474404
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive genetic analysis of overlapping syndromes of RAS/RAF/MEK/ERK pathway.
Tumurkhuu M; Saitoh M; Sato A; Takahashi K; Mimaki M; Takita J; Takeshita K; Hama T; Oka A; Mizuguchi M
Pediatr Int; 2010 Aug; 52(4):557-62. PubMed ID: 20030748
[TBL] [Abstract][Full Text] [Related]
9. Leukemia in Cardio-facio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene.
Makita Y; Narumi Y; Yoshida M; Niihori T; Kure S; Fujieda K; Matsubara Y; Aoki Y
J Pediatr Hematol Oncol; 2007 May; 29(5):287-90. PubMed ID: 17483702
[TBL] [Abstract][Full Text] [Related]
10. Two novel germline KRAS mutations: expanding the molecular and clinical phenotype.
Stark Z; Gillessen-Kaesbach G; Ryan MM; Cirstea IC; Gremer L; Ahmadian MR; Savarirayan R; Zenker M
Clin Genet; 2012 Jun; 81(6):590-4. PubMed ID: 21797849
[TBL] [Abstract][Full Text] [Related]
11. Distal phalangeal creases--a distinctive dysmorphic feature in disorders of the RAS signalling pathway?
Ørstavik KH; Tangeraas T; Molven A; Prescott TE
Eur J Med Genet; 2007; 50(2):155-8. PubMed ID: 17324647
[TBL] [Abstract][Full Text] [Related]
12. Further delineation of the phenotype resulting from BRAF or MEK1 germline mutations helps differentiate cardio-facio-cutaneous syndrome from Costello syndrome.
Gripp KW; Lin AE; Nicholson L; Allen W; Cramer A; Jones KL; Kutz W; Peck D; Rebolledo MA; Wheeler PG; Wilson W; Al-Rahawan MM; Stabley DL; Sol-Church K
Am J Med Genet A; 2007 Jul; 143A(13):1472-80. PubMed ID: 17551924
[TBL] [Abstract][Full Text] [Related]
13. Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders.
Gremer L; Merbitz-Zahradnik T; Dvorsky R; Cirstea IC; Kratz CP; Zenker M; Wittinghofer A; Ahmadian MR
Hum Mutat; 2011 Jan; 32(1):33-43. PubMed ID: 20949621
[TBL] [Abstract][Full Text] [Related]
14. Molecular confirmation of HRAS p.G12S in siblings with Costello syndrome.
Gripp KW; Stabley DL; Geller PL; Hopkins E; Stevenson DA; Carey JC; Sol-Church K
Am J Med Genet A; 2011 Sep; 155A(9):2263-8. PubMed ID: 21834037
[TBL] [Abstract][Full Text] [Related]
15. An attenuated phenotype of Costello syndrome in three unrelated individuals with a HRAS c.179G>A (p.Gly60Asp) mutation correlates with uncommon functional consequences.
Gripp KW; Sol-Church K; Smpokou P; Graham GE; Stevenson DA; Hanson H; Viskochil DH; Baker LC; Russo B; Gardner N; Stabley DL; Kolbe V; Rosenberger G
Am J Med Genet A; 2015 Sep; 167A(9):2085-97. PubMed ID: 25914166
[TBL] [Abstract][Full Text] [Related]
16. Noonan syndrome caused by germline KRAS mutation in Taiwan: report of two patients and a review of the literature.
Lo FS; Lin JL; Kuo MT; Chiu PC; Shu SG; Chao MC; Lee YJ; Lin SP
Eur J Pediatr; 2009 Aug; 168(8):919-23. PubMed ID: 18958496
[TBL] [Abstract][Full Text] [Related]
17. Molecular and clinical characterization of cardio-facio-cutaneous (CFC) syndrome: overlapping clinical manifestations with Costello syndrome.
Narumi Y; Aoki Y; Niihori T; Neri G; Cavé H; Verloes A; Nava C; Kavamura MI; Okamoto N; Kurosawa K; Hennekam RC; Wilson LC; Gillessen-Kaesbach G; Wieczorek D; Lapunzina P; Ohashi H; Makita Y; Kondo I; Tsuchiya S; Ito E; Sameshima K; Kato K; Kure S; Matsubara Y
Am J Med Genet A; 2007 Apr; 143A(8):799-807. PubMed ID: 17366577
[TBL] [Abstract][Full Text] [Related]
18. Myopathy caused by HRAS germline mutations: implications for disturbed myogenic differentiation in the presence of constitutive HRas activation.
van der Burgt I; Kupsky W; Stassou S; Nadroo A; Barroso C; Diem A; Kratz CP; Dvorsky R; Ahmadian MR; Zenker M
J Med Genet; 2007 Jul; 44(7):459-62. PubMed ID: 17412879
[TBL] [Abstract][Full Text] [Related]
19. Germline mutations in HRAS proto-oncogene cause Costello syndrome.
Aoki Y; Niihori T; Kawame H; Kurosawa K; Ohashi H; Tanaka Y; Filocamo M; Kato K; Suzuki Y; Kure S; Matsubara Y
Nat Genet; 2005 Oct; 37(10):1038-40. PubMed ID: 16170316
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial dysfunction and organic aciduria in five patients carrying mutations in the Ras-MAPK pathway.
Kleefstra T; Wortmann SB; Rodenburg RJ; Bongers EM; Hadzsiev K; Noordam C; van den Heuvel LP; Nillesen WM; Hollody K; Gillessen-Kaesbach G; Lammens M; Smeitink JA; van der Burgt I; Morava E
Eur J Hum Genet; 2011 Feb; 19(2):138-44. PubMed ID: 21063443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
